mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.02 |
mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.02 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
AZD8055 |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.02 |